Metoprolol Succinate + Hydrochlorothiazide
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
High Blood Pressure (Hypertension).
Conditions
High Blood Pressure (Hypertension).
Trial Timeline
Jun 1, 2003 → Jul 1, 2004
NCT ID
NCT00642096About Metoprolol Succinate + Hydrochlorothiazide
Metoprolol Succinate + Hydrochlorothiazide is a phase 3 stage product being developed by AstraZeneca for High Blood Pressure (Hypertension).. The current trial status is completed. This product is registered under clinical trial identifier NCT00642096. Target conditions include High Blood Pressure (Hypertension)..
What happened to similar drugs?
6 of 20 similar drugs in High Blood Pressure (Hypertension). were approved
Approved (6) Terminated (7) Active (9)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00642096 | Phase 3 | Completed |
Competing Products
20 competing products in High Blood Pressure (Hypertension).